CHAPEL HILL, N.C., Oct. 5 /PRNewswire/ -- While Megabrands are more and more an exception today and many companies invest in specialty therapeutic areas, the underlying principles of how to develop, market, sell and manage a blockbuster drug that will outperform the competition are still the same -- and are still sought after by pharmaceutical and biotech companies alike.
Best Practices, LLC's leading benchmarking report "Launching Pharmaceutical Megabrands: Best Practices in Marketing Blockbusters" delivers the critical building blocks essential for new product management pre and post launch. What separates industry leaders from other pharmaceutical executives is vital knowledge of when in the process to start building and where to focus resources during development - the report provides those answers.
For a complimentary download of research study excerpts, please visit http://www3.best-in-class.com/rr862.htm.
In the benchmarking report, research analysts compile compelling metrics, best practices and lessons learned from survey responses and in-depth interviews with 24 top executives at companies such as Pfizer, Merck, Sanofi-Aventis, GlaxoSmithKline, Eli Lilly, Amgen, Boehringer-Ingelheim and Novartis.
The myriad of insights gleaned from interviewees on such topics as marketing support investment and expense patterns for high potential products will inform all marketing and branding decision-makers throughout the drug development cycle.
To learn more about the winning tactics, proven investment patterns and other tried-and-true strategies for optimizing drug launch success, see the complimentary report summary at http://www3.best-in-class.com/rr862.htm.
To drill down on the countless metrics and best practices presented in this report contact our Solution Specialists at (919) 403-0251 or email@example.com.
If you have questions regarding your own product launch, need a health check for your marketing investments, or would like to discuss how Best Practices, LLC can support your drug marketing, launch or lifecycle initiatives, please contact Cameron Tew at 919-767-9246 or firstname.lastname@example.org.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for nearly 15 years; our clients include 43 out of the top 50 pharmaceutical companies.
|SOURCE Best Practices, LLC|
Copyright©2007 PR Newswire.
All rights reserved